Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
These requirements mirror those that may have limited adoption of Rybelsus, the oral semaglutide from Novo Nordisk approved for diabetes in 2019
Like many emerging therapies, Dihexas clinical profile has its gaps: For this reason, Dihexa should always be used with functional lab support and under physician supervision
After previously announcing a rebrand and reformulation to Rybelsus in February 2026 to make the treatment more easily recognizable and bioavailable, Novo Nordisk announced that the Ozempic pill will be available for adults with type 2 diabetes in the United States starting Monday, May 4, 2026
Sources: Sebecic B, Nikolic V, Sikiric P, et al
US$ 28.09
US$ 25.07
US$ 28.60
US$ 25.38
US$ 27.08
